Polaryx Therapeutics, Inc. Common Stock (PLYX) SEC EDGAR filings (10-Q, DEF 14A, 8-K, 10-K, S-1/A, S-1), newest first; latest 10-Q filed 2026-08-13. Every filing links to the canonical SEC document. First-party data.
| Filed | Form | Title |
|---|---|---|
| 2026-08-13 | 10-Q | 10-Q filed 2026-08-13 by Polaryx Therapeutics, Inc. |
| 2026-07-28 | DEF 14A | DEF 14A filed 2026-07-28 by Polaryx Therapeutics, Inc. |
| 2026-07-21 | 8-K | 8-K filed 2026-07-21 by Polaryx Therapeutics, Inc. |
| 2026-07-17 | 8-K | 8-K filed 2026-07-17 by Polaryx Therapeutics, Inc. |
| 2026-05-28 | 8-K | 8-K filed 2026-05-28 by Polaryx Therapeutics, Inc. |
| 2026-05-15 | 10-Q | 10-Q filed 2026-05-15 by Polaryx Therapeutics, Inc. |
| 2026-03-24 | 10-K | 10-K filed 2026-03-24 by Polaryx Therapeutics, Inc. |
| 2026-01-27 | S-1/A | S-1/A filed 2026-01-27 by Polaryx Therapeutics, Inc. |
| 2026-01-14 | S-1/A | S-1/A filed 2026-01-14 by Polaryx Therapeutics, Inc. |
| 2025-11-21 | S-1 | S-1 filed 2025-11-21 by Polaryx Therapeutics, Inc. |
PLYX overview · PLYX earnings · PLYX financials · PLYX KPIs · PLYX investor relations · PLYX ownership · PLYX peers
Data sourced from U.S. SEC EDGAR. Not personalized investment advice.